Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Kif15-IN-2 is used for the research of cellular proliferative diseases. Kif15-IN-2 is an inhibitor of the mitotic kinesin Kif15.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | 8-10 weeks | $ 198.00 | |
5 mg | 8-10 weeks | $ 347.00 | |
25 mg | 8-10 weeks | $ 1,140.00 | |
50 mg | 8-10 weeks | $ 1,490.00 | |
100 mg | 8-10 weeks | $ 1,990.00 | |
1 mL * 10 mM (in DMSO) | 8-10 weeks | $ 382.00 |
Description | Kif15-IN-2 is used for the research of cellular proliferative diseases. Kif15-IN-2 is an inhibitor of the mitotic kinesin Kif15. |
In vitro | Kif15-IN-2, a mitotic kinesin Hs Kif15 inhibitor, displays potential therapeutic activities against various cellular proliferative diseases, including cancer, hyperplasias, restenosis, cardiac hypertrophy, immune disorders, and inflammation. |
Molecular Weight | 440.48 |
Formula | C20H20N6O4S |
CAS No. | 672926-33-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 20 mg/mL (45.41 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Kif15-IN-2 672926-33-9 Others Kif15IN2 Kif-15-IN-2 Kif15 IN 2 inhibitor inhibit